IFNG and neoplasm: Moreover, IFNG and Merck18 (Fig. 9C,D), which can reflect the ability to release IFN-γ, showed that patients with low CRRGPI scores could release more IFN-γ, which indicated a stronger ability to kill the tumour (P < 0.001).